The World Health Organization (WHO) has raised alarms over a significant increase in drug-resistant bacteria, highlighting a looming innovation crisis in antibiotic development. The organization noted that antimicrobial resistance (AMR) is becoming a serious global health threat, with an estimated 1.27 million deaths attributed to resistant infections in 2019 alone. WHO emphasized that the existing antibiotics are becoming less effective, leading to prolonged illnesses and increased healthcare costs.
In its report, WHO called for urgent action to address this growing problem, including increased investment in research and development of new antibiotics and alternative therapies. The organization pointed out that fewer new antibiotics have been developed in recent decades, leading to a reliance on existing treatments that are increasingly ineffective against resistant strains.
WHO’s warning comes as the COVID-19 pandemic has further strained healthcare systems, diverting attention and resources from tackling AMR. The organization urged governments, pharmaceutical companies, and researchers to collaborate and prioritize the fight against drug-resistant infections to protect public health.
Source: news.google.com